A New Age for Early Stage Lung Cancer

Moderator(s)

• 

  Farhood Farjah, MD

  University of Washington
  Seattle, Washington, United States

  Disclosure(s): No financial relationships to disclose
• 

  Svetlana Kotova, MD

  Thoracic surgeon
  PeaceHealth hospital and OHSU
  Portland , Oregon, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 3:00 PM – 3:10 PM PT

  Incidence, Timing, and Causes of Death Among Patients Who Underwent Lobectomy forStage IA Lung Cancer in the National Lung Screening Trial
  

  Alexandra Potter, BS (she/her/hers) – Massachusetts General Hospital
• 3:10 PM – 3:20 PM PT

  A pH-activatable near-infrared nanoprobe labels diverse histologic subtypes of human lung cancer during resection
  

  Gregory Thomas Kennedy – The University of Pennsylvania Perlman School of Medicine
• 3:20 PM – 3:30 PM PT

  Segmentectomy for Less Than 2 cm Non-Small-Cell Lung Cancer with Visceral Pleural Invasion is Associated with Similar Survival as Lobectomy
  

  Camille Mathey-Andrews, MD – Massachusetts General Hospital
• 3:30 PM – 3:40 PM PT

  Summary of JCOG0802 & CALGB 140503 trials
  

  Nasser Altorki, MD – Weill Cornell Medical College
• 3:40 PM – 4:00 PM PT

  Panel discussion/Q&A
  

  David Tom Cooke, MD (he/him/his) – University of California, Davis Medical Center

  Betty C. Tong, MD – Duke University Medical Center

  Janet Edwards, MD, MPH (she/her/hers) – University of Calgary

  Nasser Altorki, MD – Weill Cornell Medical College